{
    "URL": "https://doi.org/10.1371/journal.pntd.0010588",
    "Published": "July 6, 2022",
    "Subject_Areas": [
        "Viral vaccines",
        "Vaccine development",
        "Zika virus",
        "Dengue virus",
        "Enzyme-linked immunoassays",
        "Immune response",
        "Vaccines",
        "Antigens"
    ],
    "Authors": {
        "Danielle Thompson": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America"
        ],
        "Ben Guenther": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America"
        ],
        "Darly Manayani": [
            "PaxVax Inc., San Diego, California, United States of America"
        ],
        "Jason Mendy": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America"
        ],
        "Jonathan Smith": [
            "PaxVax Inc., San Diego, California, United States of America"
        ],
        "Diego A. Espinosa": [
            "Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America"
        ],
        "Eva Harris": [
            "Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America"
        ],
        "Jeff Alexander": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America",
            "PaxVax Inc., San Diego, California, United States of America"
        ],
        "Lo Vang": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America"
        ],
        "Christopher S. Morello": [
            "Emergent BioSolutions Inc., Gaithersburg, Maryland, United States of America"
        ]
    }
}